Breast Cancer Kit - BRCAaccuTest™

Total solution for genetic breast cancer BRCA genetic test(CE-IVD)

Clinically validated next generation sequencing (NGS) panel and data analysis software for rapid and reliable detection of BRCA 1/2 mutations

BRCAaccuTestTM is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) product which detects mutations in BRCA1 /BRCA2 genes. BRCAaccuTestTM consists of NGS panel for detecting variants and clinical data analysis software (S/W). Rapid and precise detection of various mutations in BRCA 1/2 with NGS can be accomplished and the user-oriented analysis software enables convenient generation of clinical report.

Features:

• Detection of mutations in the whole exon region coding for BRCA1 and BRCA2 gene proteins
• Experiment and decryption completed in 2 days
• Using DNA extracted from blood
• PCR amplicon-based library production
• Provide data QC, analysis and automated variant information by using optimized analysis software for BRCA1 and 2 panels
• Production and management from GMP and ISO 13485 certified organizations
• CE-IVD / KFDA Class III